.svg)
Technology Sponsor
Inceptor Bio is taking a unique approach to identifying, incubating, and accelerating novel technologies. The company is focused on changing the healthcare landscape by creating 20 companies over 20 years to significantly advance progress for curing cancer and neurodegenerative diseases.
Inceptor Bio is addressing unmet medical needs with breakthrough innovations in oncology, neurosciences, and rare diseases. Significant opportunities remain in these areas, especially as the global population ages. Technology is advancing in the areas of cell and gene therapy, gene editing, immuno-oncology, RNAi, the microbiome, and precision medicine, allowing these innovative platforms to become more accessible.
Inceptor Bio is fully equipped to identify promising novel technologies, perform rigorous diligence, in-license, with funding through Proof of Principle, create new companies, build strategies and teams, and raise capital through Series A. By taking a different approach to identifying, incubating, and accelerating novel technologies, Inceptor Bio is focused on changing the landscape by creating 20 companies within 20 years to significantly advance progress for curing cancer and neurodegenerative diseases.
